Skip to content
healthcare.dev

Methotrexate

NDC 0378-0014, methotrexate, tablet, from Mylan Pharmaceuticals Inc..

Product NDC
0378-0014
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA081235
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0014 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM2.5 mg/1

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
0378-0014-0100378001401100 TABLET in 1 BOTTLE, PLASTIC (0378-0014-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/70c09984-2b36-424f-8b27-3fd0cd4e833d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0378-0014
  • NADAC price for package 00378001401

    GET /v1/drugs/nadac/00378001401

Use it

Look up 0378-0014 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0014 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-0014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.